These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Molecular epidemiology of clinical isolation of carbapenem-resistant Enterobacterales and application of carbapenemase inhibitor enhancement test. Li H; Zhong Y; Yan Q; Liu W; Liang X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1210-1216. PubMed ID: 37875361 [TBL] [Abstract][Full Text] [Related]
13. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014-2018). Gracia-Ahufinger I; López-González L; Vasallo FJ; Galar A; Siller M; Pitart C; Bloise I; Torrecillas M; Gijón-Cordero D; Viñado B; Castillo-García J; Campo R; Mulet X; Madueño-Alonso A; Chamizo-López FJ; Arrastia-Erviti M; Galán-Sánchez F; Fernández-Quejo M; Rodríguez-Díaz JC; Gutiérrez-Zufiaurre MN; Rodríguez-Maresca MA; Ortega-Lafont MDP; Yagüe-Guirao G; Chaves-Blanco L; Colomina-Rodríguez J; Vidal-Acuña MR; Portillo ME; Franco-Álvarez de Luna F; Centelles-Serrano MJ; Azcona-Gutiérrez JM; Delgado-Iribarren García Campero A; Rey-Cao S; Muñoz P; Calvo-Montes J; Zboromyrska Y; Grandioso D; Càmara J; Cantón R; Larrosa-Escartín N; Díaz-Regañón J; Martínez-Martínez L Front Microbiol; 2023; 14():1247804. PubMed ID: 37744921 [TBL] [Abstract][Full Text] [Related]
14. Multicenter Study of Carbapenemase-Producing Yu H; González Molina MK; Carmona Cartaya Y; Hart Casares M; Aung MS; Kobayashi N; Quiñones Pérez D Antibiotics (Basel); 2022 Apr; 11(4):. PubMed ID: 35453265 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017-2019. Wielders CCH; Schouls LM; Woudt SHS; Notermans DW; Hendrickx APA; Bakker J; Kuijper EJ; Schoffelen AF; de Greeff SC; ; Antimicrob Resist Infect Control; 2022 Apr; 11(1):57. PubMed ID: 35397546 [TBL] [Abstract][Full Text] [Related]
16. A Longitudinal Nine-Year Study of the Molecular Epidemiology of Carbapenemase-Producing Duong TTT; Tsai YM; Wen LL; Chiu HC; Chen PK; Thuy TTD; Kuo PY; Hidrosollo JH; Wang S; Zhang YZ; Lin WH; Wang MC; Kao CY Front Microbiol; 2022; 13():703113. PubMed ID: 35359715 [TBL] [Abstract][Full Text] [Related]
17. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae. Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I; Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670 [TBL] [Abstract][Full Text] [Related]
18. Five-Year Survey of Asymptomatic Colonization with Multidrug-Resistant Organisms in a Romanian Tertiary Care Hospital. Tălăpan D; Rafila A Infect Drug Resist; 2022; 15():2959-2967. PubMed ID: 35706926 [TBL] [Abstract][Full Text] [Related]
19. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Shortridge D; Kantro V; Castanheira M Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study. Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]